Drug combination shows promise for treating COVID-19
New findings have shown that a triple antiviral drug combination holds promise for the treatment of COVID-19.
Results from a randomised trial for treating COVID-19...
Discover how sample pooling can increase coronavirus testing capacity
A team of scientists in Germany have developed a new procedure that will help increase coronavirus testing capacity.
The development will help to increase coronavirus...
Protection against deadly, preventable diseases through European Immunisation Week
The EFN, as part of the Coalition for Vaccination, has launched a social media campaign during European Immunisation Week for nurses on vaccination for...
Drug candidate as potential therapy for cytokine release syndrome
Preclinical proof of concept of PPP003 – a synthetic cannabinoid drug – has been put forward as potential therapy in the battle against COVID-19...
Vitamin supplements boost immune system in fight against COVID-19
New findings have confirmed the efficacy of dietary vitamin supplements – including vitamin C and vitamin D – in helping the immune system fight...
Could azithromycin prevent NHS workers from developing COVID-19?
Do you think azithromycin or doxycycline administered daily to frontline NHS workers prevent them from developing COVID-19? Researchers from the University of Salford tell...
Study shows trial drug effectively blocks COVID-19 in early stages
A new study has found that a trial drug effectively blocks the early stages of COVID-19.
The drug treatment, called APN01, holds promise for stopping...
Research shows how to boost immune responses to vaccines in seniors
New research has shown how older people’s immune system response to vaccines could be boosted using immunology expertise and the surprising use of genital...
MCSS: the digital transformation of medication handling
CEO Ulrika Kjellberg tells Health Europa more about how the medication handling has transformed nursing home and residential care in Sweden.
Appva’s fully digital Medication...
Could the ancient remedy of magnolia bark treat drug-resistant epilepsy?
Researchers have published a paper which suggests the ancient Chinese remedy of magnolia bark could help treat drug-resistant epilepsy.
Researchers have published a paper in...
Pharma companies are more profitable than most S&P 500 companies
New research from Bentley University, Massachusetts, USA, reveals that big pharmaceutical companies are more profitable than most Standard & Poor (S&P) 500 companies.
The research...
Smart diabetes management market 2020 is surging
The smart diabetes management market is estimated to reach $11.93bn (€10.74bn) by 2027, according to new research by Data Bridge Market Research.
Data Bridge Market...
Next generation pharmacology research with Tetra Bio-Pharma
Tetra Bio-Pharma are pleased to announce their co-development agreement with MAKScientific – could this agreement be the advancements needed for next generation pharmacology research?
Leaders...
Tetra confirms FDA conditions met for CAUMZ drug
FDA conditions met for Fast Track programme where the patient population has a serious condition with significant morbidity.
Leaders in botanical-derived drug discovery and development,...
European pharmaceutical industry’s shared goals and responsibilities
Nathalie Moll, Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA), explores Europe’s shared goals and shared responsibilities
When EU Commission President,...
MDMA-assisted psychotherapy for PTSD approved by FDA
A new programme will enrol 50 PTSD patients for MDMA-assisted psychotherapy following FDA approval.
The non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) was recently granted...
Tetra Bio Pharma receives approval for OTC use in pain drugs
TERPACAN™, from Tetra Bio Pharma, has received approval for over the counter (OTC) use in back and muscle pain, and in hemorrhoids.
TERPACAN™ is expected...
BioNotus: your one-stop partner for contract research
BioNotus combines bioanalysis (data) with pharmacometrics (information) to deliver actionable insights
BioNotus is a contract research organisation which specialises in the bioanalysis of drugs. Johan...
Fish Odour Syndrome: Dermetel aims to give patients a breath of fresh air
Dermetel is launching two Phase I clinical trials that focus on the rare disease, Trimethylaminuria or more commonly known, fish odour syndrome.
Fish odour syndrome...
New partnership announced today is set to reduce the impact of sepsis in the UK
Beckman Coulter, the global leader in clinical diagnostics, announces today its partnership with South West London Pathology (SWLP) to reduce the impact of sepsis in...
